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ABSTRACT  Primary cultures that contain only Schwann cells and sensory nerve cells synthesize 
basal lamina. The assembly of this basal lamina appears  to  be essential  for normal Schwann 
cell  development.  In  this  study,  we demonstrate  that  Schwann  cells  synthesize  two  major 
heparan sulfate-containing  proteoglycans.  Both proteoglycans  band in dissociative  CsCI gra- 
dients at densities <1.4 g/ml, and therefore, presumably, have relatively low carbohydrate-to- 
protein ratios. The larger of these proteoglycans elutes from Sepharose CL-4B in 4 M guanidine 
hydrochloride  (GuHCI) at a Kay of 0.21 and contains  heparan sulfate  and chondroitin  sulfate 
chains of Mr 21,000 in  a ratio of ~3:1.  This  proteoglycan  is extracted  from  cultures  by 4  M 
GuHCI but not Triton X-100 and accumulates only when Schwann cells are actively synthesiz- 
ing basal lamina.  The smaller proteoglycan elutes from  Sepharose  CL-4B at a Kav of 0.44 and 
contains  heparan sulfate  and chondroitin  sulfate  chains  of Mr 18,000 in a ratio of ~4:1. This 
proteoglycan  is  extracted  by  4  M  GuHCI  or  by  Triton  X-100.  The  accumulation  of  this 
proteoglycan is independent of basal lamina production. 
The extracellular matrix (ECM)'  profoundly affects the be- 
havior and  development of many kinds  of cells.  Unfortu- 
nately, however, the detailed mechanisms underlying these 
effects are usually not known (reviewed in references 1-4). In 
recent  years,  significant  advances  have  been  made  in  our 
understanding of the biochemical nature of the ECM, high- 
lighted by the isolation and characterization of several of its 
major macromolecular components. Most extracellular mat- 
rices contain  three classes of macromolecules: collagens, of 
which there are at least five genetically distinct types; glyco- 
proteins (such as fibronectin and laminin); and proteoglycans 
(1).  Each  specific ECM  component possesses a  distinctive 
tissue  distribution  and  presumably, a  distinct  function.  Of 
particular interest from the latter group are heparan sulfate- 
containing  proteoglycans that  are present  in  basal laminae 
(5-9) as well as plasma membranes (10-12) of certain cells. 
Primary cell  cultures of embryonic rat Schwann cells and 
sensory nerve cells provide a  useful system for studying the 
Abbreviations used in this paper: ECM, extracellular matrix; GuHCI, 
guanidine  hydrochloride; N2FA, N2  medium  supplemented with 
fetuin and ascorbic acid; PG 1 and PG2, proteoglycan fractions. 
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biosynthesis and biological effects of ECM. In these cultures, 
a basal lamina is formed that covers the outer surface of the 
Schwann  cells and morphologically resembles the Schwann 
cell basal lamina produced in vivo (13,  14). Biochemical and 
immunochemical experiments have shown that Schwann cells 
are the source of the collagens and glycoproteins (primarily 
laminin) present in the basal lamina (13,  15-17). Basal lamina 
formation, however, proceeds only in the presence of nerve 
cells  (14).  Recent experiments indicate that  nerve cells  are 
required  for  maintaining  high  levels  of  production  by 
Schwann cells of type IV collagen, a major constituent of the 
basal lamina (16). Treatments that prevent basal lamina for- 
mation  in  culture  block  the  later  stages  of Schwann  cell 
differentiation,  namely  myelination and  unmyelinated  en- 
sheathment of nerve fibers (18,  19), suggesting  that the basal 
lamina carries out an important function in peripheral nerve 
development. The mechanism of this effect of basal lamina 
on Schwann cells is not understood. 
Most of the work to date on the Schwann  cell ECM  has 
been either ultrastructural or has concentrated on the collagen 
and glycoprotein constituents of the matrix. The accumula- 
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roles in ECM (2,  20-23) has prompted us to examine their 
presence in Schwann cell-nerve cell cultures. Here we report 
that Schwann ceils synthesize two major low-density heparan 
sulfate proteoglycans that differ in size and apparent distri- 
bution. 
MATERIALS  AND  METHODS 
Cultures:  Primary  cultures of Schwann cells and nerve cells were pre- 
pared from dorsal root ganglia of embryonic rats (Sprague-Dawley strain, from 
Dominion Laboratories, Dublin, VA) as described earlier (13, 15, 19, 24). Both 
explant and dissociated cell cultures were used in the studies reported here and 
gave similar results. 
Radiolabeling:  Cultures were labeled with 3~SO4 (carrier-free sulfuric 
acid, obtained  either from New England Nuclear, Boston, MA, or ICN Phar- 
maceuticals, Inc., irvine, CA) by an incubation  in Ham's F-12 medium con- 
taining 200 #Ci/ml J~SO4 with or without the additives indicated in Results for 
up to 48 b. In some experiments, the labeling medium also contained  50 uCi/ 
ml 6-[3H]glucosamine (30 Ci/mmol, ICN Pharmaceuticals,  Inc.). At the end of 
the labeling period, the medium was removed, the cultures were rinsed once 
with 0.05 M Na-phosphate, 0.15 M NaCl, pH 7.5 containing protease inhibitors 
(2 mM phenylmethylsulfonyl  fluoride, 4 mM benzamidine,  l0 mM EDTA), 
and the medium and rinse were pooled. The cultures were rinsed twice more 
with  the  same  buffer.  Cultures  were  extracted  overnight  at 4"C  with  4  M 
guanidine  hydrochloride  (GuHCI), 0.05 M Na-acetate, pH 5.0, 0.05% Triton 
X-150 containing  protease  inhibitors  (0.5 ml/culture).  In some experiments, 
cultures were extracted with  1% Triton X-100, 0.05 M Tris-HCl, pH 7.4 plus 
protease  inhibitors  for  l  h  at 4"C  before GuHC1 extraction.  To quantitate 
extraction  of 35SO4-1abeled macromolecules  by 4  M GuHCI,  the  remaining 
cellular material  was dissolved in 0.5 N NaOH.  4 M GuHCI extracted ~75% 
of the cell-associated macromolecular  35SO4. 
Proteoglycan Analysis:  Radiolabeled  proteoglycans were separated 
from unincorporated  isotope by chromatography  on a  l  x  30-cm column of 
Sepbadex G-50 with 4 M GuHCI buffer as the eluting buffer. The radioactive 
material eluting in the void volume was pooled. The radiolabeled proteoglycans 
were concentrated  by precipitation  with  1.3% potassium acetate/95%  ethanol 
(-20"C, overnight) and redissolved in 4 M GuHC1 buffer or another appropriate 
solvent. This procedure also eliminated  a~so4-1abeled organic-soluble material 
(presumably sulpholipids) from the proteoglycan fractions. 
Equilibrium density gradient centrifugation was performed on some proteo- 
glycan samples. Solid CsCI was added to proteoglycans in 4 M GuHCI buffer 
to a final density of 1.45 g/ml. Centrifugation was done for 48 h in a Beckman 
SW50.1 rotor (Beckman  Instruments, Inc., Palo Alto, CA) at  35,000 rpm at 
10*C. Gradients  were  fractionated  by  piercing  tubes from the  bottom and 
collecting 0.5-ml fractions. 
Proteoglyeans  were  separated  preparatively  on  1 x  100-cm columns of 
Sepharose CL-4B equilibrated and eluted with 4 M GuHCI buffer at a flow rate 
of 6 ml/h. Glycosaminoglycans were liberated from proteoglycan core proteins 
by hydrolysis in 0.05 M NaOH,  1 M NaBH4 at 45"C for  16 h (25). Sizes of 
glycosaminoglyeans were determined by chromatographing them on a 1 x  100- 
cm column of Sepharose CL-4B eluted with 4 M GuHCI buffer and calibrated 
with  chondroitin  sulfate  chains  isolated  and  characterized  as  described  by 
Wasteson (26). Glycosaminoglycans were treated  separately with nitrous acid 
(27)  and  chondroitinase  ABC  (25). Degradation  of glycosaminoglycan was 
determined  by chromatography  on Sephadex G-50. 
Monodonal Antibody:  Details concerning the isolation and initial 
characterization of monoclonal antibodies that recognize Schwann cell antigens 
will be presented elsewhere.  2 Briefly, mice were injected with a homogenate of 
l-mo-old primary Schwann cell-nerve cell cultures and boosted with a homog- 
enate  of rat postnatal  day 6 sciatic nerve. Spleen cells from these mice were 
fused with  mouse myeloma cells, and culture  media  of hybrid  clones were 
screened  for  antibodies  that  bound  to  primary cultures  of embryonic  rat 
Schwann cells and nerve cells. The antibody  produced  by clone B3,  used in 
this study, binds to an antigen present in cultures grown in medium containing 
serum and chick embryo extract but not in N2 medium. By indirect  immu- 
nofluorescence, the antibody  stains adult rat sciatic nerve sections in a pattern 
identical to that of basal lamina components such as laminin  or collagen type 
IV. In immunoblot or immunoprecipitation  reactions, the antibody  does not 
bind to laminin,  fibronectin, collagen, or other known matrix proteins. 
Immunoprecipitation:  Proteoglycans, extracted  from 35SO4-1abeled 
2 Cornbrooks, C. J., C. Eldridge, J. Sanes, D. Gottlieb, and R. Bunge. 
Manuscript in preparation. 
cultures  with  4  M  GuHCI,  were dialyzed  overnight  at  4"C vs 0.05 M Na- 
phosphate, 0.15 M NaCI, pH 7.5. Ascites fluid containing the mouse monoclo- 
hal antibody  B3 was added (5 ul/ml of proteoglycan solution) and incubated 
at 4'C for 3 h. Antigen-antibody  complexes were precipitated by the addition 
of Pansorbin cells (Calbiochem-Behring Corp,, La Jolla, CA) (250 #1 of a 10% 
suspension per milliliter of proteoglycan solution).  The resulting pellets and 
supernatants  were diluted with 4 M GuHC1 buffer and chromatographed  on 
Sepharose CL-4B as described above. 
Imrrlurlofloorescence:  Schwann cell-nerve cell cultures were rinsed 
with Leibovitz Ll5 medium and incubated  for l  h at 4"C with B3 antibody 
( 1:200 dilution ofascites fluid) in Leibovitz L15 medium containing  10% heat- 
inactivated horse serum. The cultures were rinsed with L15-10% horse serum, 
fixed in  3%  paraformaldehyde  at  room temperature  for 30  mix and  then 
incubated  with  affinity purified  fluorescein-conjugated goat  anti-rabbit IgG 
(1:20 dilution) for 30 mix. After the cultures were rinsed, they were mounted 
on glass slides and viewed under a Nikon diapot  inverted microscope (Nikon 
Inc., Garden City, NY) equipped for epifluorescence. 
RESULTS 
Selective Accumulation of a Sulfated 
Macromolecule during Basal Lamina Formation 
Schwann cell-nerve cell cultures can be grown under con- 
ditions in which axonal growth and Schwann cell proliferation 
occur normally, but basal lamina formation, and ensheath- 
merit and myelination of axons by Schwann ceils do not occur 
(15,  19). Basal lamina formation can be initiated by adding 
certain components to the culture medium, which also results 
in ensheathment and myelination of axons (15,  19;  Carey, 
D., and M. Todd, manuscript submitted for publication). We 
were interested in identifying proteoglycans that are present 
constitutively as well as proteoglycans that accumulate only 
during basal lamina formation. Cultures were grown in the 
serum-free defined medium N2, in which no ultrastructurally 
detectable basal lamina is formed (19).  After 4  wk in  this 
medium, groups of cultures were  switched to  N2  medium 
supplemented with fetuin (I  mg/ml) plus ascorbic acid (50 
#g/ml) (N2FA medium) to initiate basal lamina formation 
(Carey, D., and M. Todd, manuscript submitted for publica- 
tion). The remaining cultures were kept in N2 medium. After 
2  d,  both  groups  of cultures  were  labeled  with  35SO4 as 
described  in  Materials  and  Methods.  Table  I  shows  the 
amounts of 3sSO4-1abeled macromolecules in the culture me- 
dia and 4 M GuHC1 extracts of these cells. In the N2 cultures, 
most of the 35SO4-1abeled molecules were in the culture me- 
dium,  whereas in  N2FA  cultures,  a  greater portion  of the 
labeled molecules were in the 4 M GuHC1 extract. The total 
amount of 35SO4-1abeled macromolecules (medium plus cell- 
associated) in N2FA cultures was approximately twice of that 
in  N2  cultures.  This difference was largely because N2FA 
cultures, which were actively forming basal lamina, accumu- 
lated greater than three times more GuHCl-extractable 3sSO4- 
labeled macromolecules than did N2 cultures. In contrast, the 
amounts of 35SO4-1abeled macromolecules in the culture me- 
dia in the two types of cultures were nearly the same. 
TABLE  I.  Effect  of Culture  Conditions  on Accumulation of 35504- 
labeled Macromolecules  in Schwann Cell-Nerve Cell Cultures 
Experi- 
ment  Compartment  N2  N2FA  N2FA/N2 
cpm/culture 
Culture medium  11,250  13,000  1.2 
Guanidine extract  5,000  16,300  3.3 
Culture medium  9,080  11,130  1.3 
Guanidine extract  3,132  10,130  3.2 
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from N2 and N2FA cultures to gel filtration chromatography 
on Sepharose CL-4B in 4  M  GuHC1 buffer.  Typical results 
are shown in Fig. 1. The extracts obtained from N2FA cultures 
contained  one  major  broad  35SO4-containing peak  eluting 
with a K~ of 0.21, and a second smaller peak eluting with a 
K,~ of 0.44.  The N2 material  contained 35SO4-labeled  peaks 
eluting at the same positions; the relative amounts of the two 
peaks, however, were different. When calculated per culture, 
there was ~8 times more radioactivity in the peak of K,v = 
0.21 in N2FA cultures than in N2 cultures, but only 1.3 times 
more radioactivity in the peak of K~ =  0.44.  These results 
indicate that the increased accumulation of radioactivity in 
N2FA cultures was due to the selective accumulation of the 
material ofK,  v = 0.21. Furthermore, significant accumulation 
of this  molecule occurred only when  the basal  lamina was 
being formed, whereas accumulation of the  material  eluted 
later (K,~ = 0.44) was independent of basal lamina formation. 
Biochemical Characterization 
To further analyze these sulfated macromolecules, column 
fractions  were  pooled  and  aliquots  of each  material  were 
rechromatographed  on  Sepharose  CL-4B  in  4  M  GuHC1. 
Additional aliquots were subjected to mild alkaline hydrolysis 
as described in Materials and Methods and then chromato- 
graphed on the  same column.  Results  for the  material  ob- 
tained  from the  major  peak  that  eluted  early  from  N2FA 
cultures are shown in Fig. 2. The rechromatographed material 
eluted  at  the  same position  (K~ =  0.21)  as in  the  original 
chromatogram (see Fig.  1), and the alkaline-hydrolyzed ma- 
terial, as a single peak that eluted later (K~ =  0.64). Identical 
results were obtained for the material that eluted early from 
N2  cultures  (not  shown).  This  behavior  is  what  would  be 
expected  for  a  proteoglycan,  with  the  alkaline-hydrolyzed 
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FIGURE  1  Sepharose  CL-4B  chromatography  of  35SO4-1abeled 
macromolecules extracted  by 4 M GuHCI. 4-wk-old Schwann cell- 
nerve cell cultures  grown in N2 medium were incubated in N2FA 
(a) or N2 medium (b) for 2 d and then labeled with 3sSO4 in Ham's 
F12 medium with 10 ng/ml nerve growth factor with (a) or without 
(b) 50 pg/ml ascorbate and 1 mg/ml fetuin for 48 h. The cells were 
extracted  with 4 M GuHCI as described in Materials and Methods. 
The graphs represent the radioactivity present in equal  numbers of 
cells.  Fraction  sizes  were  1  ml.  Arrows  indicate  excluded  and 
included  volumes. 
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FIGURE 2  Sepharose CL-4B chromatography  of sulfated proteogly- 
can before and after alkaline hydrolysis. The peak of 3sSO4-1abeled 
material eluting at Ka~ = 0,21 obtained from 4 M GuHCI extracts of 
N2FA cultures was pooled and rechromatographed on Sepharose 
CL-4B before (0) and after (O) alkaline/borohydride hydrolysis as 
described  in Materials and Methods.  Elution was with 4 M GuHCl 
buffer;  fraction  sizes were 0.7  ml. Arrows  indicate excluded and 
included volumes. 
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FIGURE  3  Nitrous acid and chondroitinase ABC digestion of alka- 
line-hyO, ~iyzed sulfated  proteoglycan.  The peak of 3sso4-1abeled 
material  ,  .ing at  Kay =  0.21 obtained from  N2FA cultures  was 
subjected to a!kaline/borohydride  hydrolysis. Aliquots were treated 
separately with nitrous acid (0) or chondroitinase  ABC (O) and then 
applied to a Sephadex G-50 column. Fraction sizes were 1 ml. 
proteoglycan core protein.  When this Sepharose CL-4B col- 
umn was calibrated with chondroitin sulfate glycosaminogly- 
can chains, a Kay of 0.64 was found to correspond to an Mr 
of 21,000. Similar experiments were done for the material in 
the  second peak (Kay =  0.44)  obtained  from both  N2  and 
N2FA cultures. The rechromatographed material eluted as a 
single peak with a Kav of  0.44, whereas the alkaline-hydrolyzed 
material eluted as a single peak with a Ka, of 0.68, correspond- 
ing to a glycosaminoglycan of Mr 18,000 (data not shown). 
To further support the conclusion that these two molecules 
are  sulfated  proteoglycans,  aliquots  of alkaline-hydrolyzed 
samples were digested separately with  nitrous acid or chon- 
droitinase ABC. In the experiments shown in Fig. 3, -70% 
of the 35SO4 radioactivity in alkaline-hydrolyzed peak  1 (Ka~ 
=  0.21) from N2FA cultures was degraded by nitrous acid, 
and  -30%  was degraded by chondroitinase ABC. Identical 
results  were  obtained  for  the  material  obtained  from  N2 
cultures (not shown). In four such experiments, the range of 
nitrous acid-degradable 35SO4-1abeled material was 70-85% 
(mean 75%).  Together with the data presented above, these 
results indicate that the molecule of Kav= 0.21  is a sulfated 
proteoglycan with glycosaminoglycans of Mr 21,000, approx- 
imately three-fourths of  which are heparan sulfate (or heparin) 
and one-fourth of which are chondroitin sulfate (or dermatan sulfate).  Alternatively,  this  fraction  could  contain  a  major 
heparan sulfate proteoglycan plus contaminating chondroitin 
sulfate proteoglycans (see below). When similar analyses were 
carried out for peak 2 (Kav =  0.44) alkaline-hydrolyzed ma- 
terial,  the  results  indicated  the  presence  of both  heparan 
sulfate and chondroitin  sulfate in a  ratio of ~4:1  (data not 
shown).  For convenience, these proteoglycan fractions have 
been designated PG 1 and  PG2 for the species eluting early 
and late, respectively. 
To determine whether the heparan sulfate and chondroitin 
sulfate were attached to the same core protein, 3sso4-1abeled 
GuHCI-extracted proteoglycans were digested with chondroi- 
tinase ABC and then analyzed by Sepharose CL-4B chroma- 
tography. As expected, the enzyme treatment caused a reduc- 
tion in the amount of radioactivity eluting in the proteoglycan 
region but did not cause a detectable shift in elution volumes 
of the proteoglycans (data not shown). This result is consistent 
with the presence of separate heparan sulfate and chondroitin 
sulfate proteoglycans. 
When 4 M GuHC1 extracts of cells were subjected to CsCI 
equilibrium density gradient centrifugation in the presence of 
4  M  GuHC1,  -70%  of the total macromolecular 35SO4, in- 
cluding essentially all of PG1  and PG2, banded at densities 
< 1.4 g/ml (data not shown). 
PC1 and PC2 Are Synthesized by Schwann Cells 
The  collagens  and  laminin  present  in  the  Schwann  cell 
basal lamina are produced by Schwann cells and not by nerve 
cells  (15-17),  yet nerve cells are  required  for basal lamina 
formation  (14).  For  this  reason,  we  wanted  to  determine 
whether Schwann  cells,  nerve cells,  or both,  synthesize the 
two proteoglycans described above. Dorsal root ganglion ex- 
plant cultures containing Schwann cells and nerve cells were 
grown in N2FA medium. Just before the cultures were labeled 
with  35SO4, the  explant  regions  were  excised,  leaving  the 
outgrowth of nerve fibers and associated Schwann cells.  Be- 
cause  the  excised  explants  contained  all  the  neuronal  cell 
bodies (the site of nerve cell protein synthesis), any synthesis 
of labeled proteoglycans detected after removal of the explant 
must have been due to Schwann cells.  Removal of the neu- 
ronal cell bodies caused no significant decrease in the amounts 
of sulfated proteoglycan produced.  Furthermore,  Sepharose 
CL-4B profiles of 4  M  GuHCl-extracted material obtained 
from cultures  from which  the  explants had  been  removed 
were indistinguishable from those of control cultures labeled 
with the explant intact (data not shown). From these results, 
we conclude that PG 1 and PG2 are synthesized by Schwann 
cells and are synthesized by nerve cells either in very small 
amounts or not at all. 
A Mouse Monoclonal Antibody to Basal Lamina 
Recognizes PC 1 
Recently, a mouse monoclonal antibody that recognizes a 
component of the Schwann cell basal lamina has been iso- 
lated.  2 This antibody recognizes a heparan sulfate proteogly- 
can present in the culture medium of Schwann cell-nerve cell 
cultures; the same proteoglycan is also recognized by antibod- 
ies  to  a  tumor-derived basement  membrane proteoglycan, 
BM-1  (see reference 5; and Eldridge, C., personal communi- 
cation). We tested this monoclonal antibody for its ability to 
bind in an immunoprecipitation reaction to the cell-associated 
sulfated proteoglycans produced by Schwann cells. Proteogly- 
cans were  extracted with  4  M  GuHC1  from  35SO4-1abeled 
Schwann cell-neuron cultures, dialyzed against 0.05  M  Na- 
phosphate,  0.15  M  NaC1,  pH  7.4,  and  then  mixed  with 
antibody. After precipitation of the immune complexes, the 
pellets and supernatants were diluted into 4 M GuHC1 buffer 
and subjected to Sepharose CL-4B chromatography. As shown 
in Fig. 4, the immunoprecipitate contained only material that 
eluted as PG1, whereas the supernatant solution contained 
only material that eluted as PG2. A control immunoprecipi- 
tate from a  tube incubated without antibody contained no 
35SO4-containing peaks (Fig. 4). Biochemical analysis of these 
materials as described above confirmed they were PG1  and 
PG2 (not shown). From these results, we conclude that the 
mouse antibody recognizes PG 1 but not PG2. 
We  used  this  monoclonal  antibody to  stain  by indirect 
immunofluorescence living,  unfixed Schwann cell-nerve cell 
cultures grown in either N2 or N2FA medium. As shown in 
Fig. 5, and in agreement with previous results/N2  cultures 
stain  very lightly,  if at all,  with  this antibody.  In contrast, 
cultures induced to form basal lamina by incubation in N2FA 
medium exhibited bright and specific staining. The pattern of 
extracellular staining  of N2FA  cultures  resembled qualita- 
tively that of other basal lamina components such as laminin 
(not shown, but see reference 17) or collagen type IV (Fig. 5, 
inset; see also reference 16). These results support the conclu- 
sion derived from the biochemical studies that PG1 accumu- 
lates only during active basal lamina formation. 
Effect of Neuronal Deprivation on Schwann Cell 
Proteoglycan Accumulation 
To provide further evidence that the increased accumula- 
tion  of PG1  in  N2FA  cultures  was  due  to  basal  lamina 
formation and  not  to  other  effects of altering the  culture 
medium, we compared the sulfated proteoglycans present in 
cultures  containing  both  Schwann  cells and  nerve cells to 
those  in  cultures containing  only Schwann  cells.  Schwann 
cells cultured in the absence of nerve cells do not synthesize 
new basal lamina (14). For these experiments, Schwann cell- 
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FIGURE  4  Immunoprecipitation of  PG1  with  a  monoclonal anti- 
body. Schwann cell-nerve cell  N2FA cultures were labeled with 
3sSO4, and  the cells were extracted with  4  M  GuHCI.  The  4  M 
GuHCl-extracted  macromolecules were dialyzed vs  0.05  M  Na- 
phosphate, 0.15 M  NaCl, pH  7.5 and  incubated with the mouse 
monoclonal antibody B3  as described  in  Materials and Methods. 
The  immunoprecipitated material (e)  and  supernatant  (x)  were 
diluted with  4  M  GuHCI  buffer  and  aliquots were applied to a 
Sepharose CL-4B  column and eluted with  4  M  GuHCI  buffer. A 
control immunoprecipitate, from an incubation with  nonimmune 
IgG, was analyzed in the same way (O). Fraction sizes were 0.8 ml. 
Arrows indicate excluded and included volumes. 
MEHTA  ET  AL.  Schwann  Cell Heparan Sulfate Proteoglycans  663 FIGURE  5  Indirect immunofluorescence of Schwann cell-nerve cell cultures with anti-PG1  monoclonal antibody. Cultures grown 
in N2 for 4 wk were keep in N2 medium (A) or switched to N2FA medium (B). After 5 d, the cultures were processed for indirect 
immunofluorescence  using the  mouse  monoclonal antibody B3  which  was  shown  to  recognize  PG1  (see  Fig.  4).  The  nuclear 
fluorescence  in  both  micrographs is not due to the antibody (not shown).  Note in the  N2FA culture (B) the linear extracellular 
staining pattern  characteristic  of Schwann  cell  basal  lamina staining.  The  inset in  B shows  an  N2FA  culture  stained with  anti- 
collagen IV antiserum. This antiserum does not stain N2 cultures  (not shov :l).  Both specimens were prepared for immunofluo- 
rescence, photographed, and printed under identical conditions, x  490. 
nerve cell  explant cultures were grown  for 4  wk in  N2FA 
medium,  during  which  time  active basal  lamina  synthesis 
occurs. At this time, the ganglia were excised from half the 
cultures.  After this treatment, both groups of cultures were 
incubated for an additional  1 wk to allow the Schwann cells 
to phagocytose the axotomized neuritic processes in the out- 
growth of ganglion-excised cultures.  It has been shown (14) 
that after neuronal excision, the existing basal lamina persists 
but no new basal lamina is formed by Schwann cells.  1 wk 
after excision of the ganglia, the cultures were labeled with 
35SO4, and  the  4  M  GuHCl-extracted  proteoglycans  were 
analyzed by Sepharose CL-4B chromatography. As shown in 
Fig. 6, the proteoglycan profile obtained from the nerve cell- 
containing cultures was typical of N2FA cultures. In contrast, 
the  proteoglycan profile of the  Schwann  cell  cultures more 
closely resembled that  of N2  cultures,  with  a  significantly 
reduced amount of PG1. This result supports the conclusion 
that increased accumulation of PG2 occurs only during basal 
lamina formation. 
PC2 but Not PC1  Is Solubilized by Detergent 
Some cell-surface heparan sulfate proteoglycans are thought 
to reside in membranes as integral membrane proteins (10, 
12). To determine whether either of the Schwann cell proteo- 
glycans described above might be associated with membranes, 
we measured the ability of 1% Triton X-100 to extract these 
proteoglycans from  35SO4-1abeled cultures.  Extraction  with 
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FIGURE  6  Effect  of  neuronal  deprivation  on  accumulation  of 
Schwann cell proteoglycans. Schwann cell  neuron exptant cultures 
were  grown  in  N2FA  medium  for  5  wk.  The  nerve  cells  were 
removed from half the cultures by excising the ganglionic explants, 
and all the cultures were incubated for an additional I  wk in N2FA 
medium.  At that time,  the cultures  were labeled with  3sSO4, and 
the 4  M  GuHCI-extracted  proteolglycans were analyzed on Seph- 
arose  CU4B  columns.  (a)  Schwann  ceils  with  nerve  cells;  (b) 
Schwann  cells  only.  Fraction  sizes  were  0.5  mi.  Arrows  indicate 
excluded and included volumes. 
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and extracts soluble proteins but not cytoskeletal or extracel- 
lular  matrix  proteins  from  these  cells  (reference  16;  and 
unpublished  observations). We  observed that the  detergent 
extracted  14-20%  (range of three experiments) of the total 
cell-associated 35SO4-1abeled proteoglycans in N2FA cultures. 
Results of gel filtration chromatography on Sepharose CL-4B 
of the Triton-extracted material is shown in Fig. 7. The major 
35S-containing  peak eluted at a Kav of 0.44. This material was 
indistinguishable from PG2 based on alkaline hydrolysis, and 
nitrous  acid  and  chondroitinase  ABC  digestion  (data  not 
shown). In addition, the detergent extracts contained variable 
amounts of 35SO4-1abeled material that eluted at a K,v of 0.7 
(Fig.  7),  and  that  was  predominantly  free  heparan  sulfate 
(data not shown). Only small amounts of material that eluted 
as PGI were detected in the detergent extracts. Nearly iden- 
tical results were obtained for N2 cultures, except that a larger 
percentage of the  total  35SO4-1abeled macromolecules were 
extracted by Triton X-100 (28 and 34% in two experiments). 
This difference reflects the larger proportion of total proteo- 
glycan that is PG2 in these cultures. When Triton-extracted 
cultures were then extracted with 4 M GuHCI, an additional 
and approximately equal amount of material similar to PG2 
was extracted.  Thus,  either two  proteoglycans with  similar 
properties, one membrane-associated and one not, are made 
by Schwann  cells,  or PG2  is membrane-associated but not 
quantitatively extracted by the conditions used. 
DISCUSSION 
The results presented demonstrate that Schwann cells synthe- 
size two major heparan sulfate-containing proteoglycans that 
differ in size and apparent distribution. The larger proteogly- 
can, which we termed PG1,  accumulates only during basal 
lamina  formation  and  is  not  extractable  by  detergent.  A 
monoclonal antibody that recognizes this proteoglycan in an 
immunoprecipitation  reaction  stains  the  outer  surface  of 
Schwann cells in a pattern similar to that of  other basal lamina 
components. This antibody does not stain Schwann cells that 
lack a basal lamina coverage. These observations suggest that 
PG1 is a component of the Schwann cell basal lamina. Proof 
of this localization must await immunoelectron microscopic 
analysis. 
The major Schwann cell  heparan sulfate proteoglycans as 
isolated by gel filtration chromatography contain significant 
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FIGURE 7  Sepharose CL-4B chromatography of Triton X-100-ex- 
tracted  Schwann cell proteoglycans.  Schwann cell-nerve cell ex- 
plant cultures were grown in N2 for 4 wk followed by 3 d in N2FA. 
The cultures were labeled with 35SO4 and extracted with 1% Triton 
X-100 as described  in Materials and Methods. The Triton X-100- 
extracted macromolecules were diluted with 4  M  GuHCI  buffer, 
applied to a Sepharose CL-4B column, and eluted with 4 M GuHCI 
buffer.  Fraction  sizes were 0.8  ml.  Arrows indicate excluded and 
included volumes. 
amounts  of  chondroitin  sulfate.  Digestion  of  GuHCl-ex- 
tracted proteoglycans with chondroitinase ABC did not cause 
a detectable shift in the elution volumes on Sepharose CL-4B 
of the major Schwann cell proteoglycans, a result consistent 
with the presence of separate heparan sulfate and chondroitin 
sulfate proteoglycans. In general, heparan sulfate-containing 
proteoglycans do not contain other glycosaminoglycans (e.g., 
5,  7,  10,  12). Chondroitin  sulfate proteoglycans have been 
shown to be present in peripheral nerves in the Schwann cell 
basal lamina and surrounding extracellular matrix (28). Inter- 
estingly, the glycosaminoglycan composition of 3sSO4-1abeled 
macromolecules did not differ significantly between N2 and 
N2FA cultures (not shown). Thus, increased accumulation of 
one  or  more chondroitin  sulfate proteoglycans may occur 
along with increased accumulation of PG 1. Not surprisingly, 
fibroblasts obtained from dorsal root ganglia produce large 
amounts of chondroitin  sulfate proteoglycans (unpublished 
observations). Further experiments will be required to deter- 
mine the properties of  these chondroitin sulfate proteoglycans. 
Our results indicate the synthesis by Schwann cells of two 
distinct heparan sulfate proteoglycans. A possibility we cannot 
entirely rule out,  however, is that the smaller proteoglycan, 
PG2, is a catabolic product of the larger, and that the conver- 
sion to PG2 is slowed or prevented in N2FA medium. Several 
lines of evidence, however, lead us to favor the idea that they 
are distinct. First, the rate of accumulation of PG2 appears to 
be independent  of culture  conditions,  and  only PG1  accu- 
mulation increases when the basal lamina is being formed. 
While a scheme in which PG2 is formed from PG 1 is not in 
principle inconsistent with this data, we believe the fortuitous 
result that the amount of PG2 present is unaltered, whereas 
the  amount  of PG1  increases  dramatically  under  certain 
conditions,  is  unlikely.  Second,  in  preliminary pulse-chase 
radiolabeling experiments measuring the  rates  of synthesis 
and  turnover  of the  Schwann  cell  proteoglycans, we  have 
found no kinetic evidence for a conversion of PG 1 to PG2 
(unpublished observations). Finally, the observation that Tri- 
ton X-100 extracts PG2, but not PG1, while not conclusive, 
is consistent with these being distinct proteoglycans. A defin- 
itive answer to this question will require a detailed analysis of 
the rates of synthesis and turnover of the proteoglycans under 
various culture conditions. 
Heparan sulfate proteoglycans have been shown to be pres- 
ent  in  many  basal  lamina  (5-9).  Unfortunately,  however, 
detailed information on individual  basal lamina proteogly- 
cans is rather scarce, due largely to the difficulties of isolating 
basal lamina components in pure form with nondegradative 
techniques. For this reason, basement membrane-producing 
tumors or cell  lines derived from tumors have been widely 
used.  The  EHS  murine  sarcoma and  the teratocarcinoma- 
derived PYS-2 cell line produce structurally distinct but im- 
munologically related  heparan  sulfate proteoglycans (5,  7). 
These proteoglycans differ from the Schwann cell basal lamina 
proteoglycan in  apparent overall size and buoyant density. 
Antibodies to the mouse tumor proteoglycan, however, stain 
Schwann cells in an indirect immunofluorescence assay (Eld- 
ridge,  C.,  personal  communication).  Thus,  although  these 
proteoglycans may differ in  their final structure,  their core 
proteins may be similar or identical.  Similarly, the isolated 
perfused rat kidney has been  shown to  produce two basal 
lamina-associated proteoglycans, a high buoyant density hep- 
aran sulfate proteoglycan, and a low-density chondroitin sul- 
fate proteoglycan (6).  Neither of these proteoglycans appear 
MEHTA ET At.  Schwann  Cell Heparan Sulfate Proteoglycans  665 to be identical to Schwann cell PG 1 or the other basal lamina 
proteoglycans, although antibodies to the mouse tumor pro- 
teoglycan also stain the glomerular basement membrane (5). 
Obviously, more work will be required to clarify the relation- 
ship among these basal lamina-associated proteoglycans. The 
availability  of a  monoclonal  antibody  that  recognizes the 
Schwann cell basal lamina proteoglycan should make it pos- 
sible to isolate and characterize the polypeptide  portion of 
this proteoglycan. 
The precise arrangement of PGI in the basal lamina re- 
mains to be determined. The molecular interactions respon- 
sible for binding together the components of basal lamina are 
not completely understood, although several types of inter- 
actions have been identified. These include the self-association 
of collagen type  IV  molecules (29,  30)  and the binding  of 
laminin to other molecules, including collagen type IV, hep- 
aran sulfate proteoglycan (4), and a cell surface receptor (31). 
We  do  not  know whether the  Schwann  cell  basal  lamina 
proteoglycan reported in this study binds to collagen type IV. 
Experiments to examine the interactions among the Schwann 
cell basal lamina components are in progress. 
In  contrast to  PGI,  the  smaller Schwann  cell-produced 
proteoglycan, PG2, is present in significant amounts in cul- 
tures lacking basal lamina. A significant fraction of this pro- 
teoglycan  (up  to  one-half)  is  extracted  by  Triton  X-100, 
which solubilizes cell membranes but not the Schwann cell 
basal lamina. These results suggest that PG2 is associated with 
cell  membranes,  either  directly  as  an  integral  membrane 
protein, or by its binding to an integral membrane compo- 
nent. Examples of both types of membrane interaction exist 
for proteoglycans in other tissues (10,  12).  The inability to 
extract all of the PG2 with Triton X- 100 indicates either that 
there are two similar proteoglycans with different localizations 
within the cell or there is a single proteoglycan, a portion of 
which is bound to detergent-insoluble cellular structures. The 
observation that the detergent extractability of PG2 was not 
altered by the presence or absence of basal lamina suggests it 
is  not bound  to extracellular matrix  molecules.  A  possible 
explanation  is  that  PG2  binds  to  intracellular cytoskeletal 
structures. Preliminary evidence for an interaction between 
the cytoskeleton and a membrane proteoglycan in mammary 
epithelial cells has been published (32). Experiments to further 
characterize this proteoglycan and the nature of its association 
with the Schwann cell membrane are in progress. 
The functions of these proteoglycans are not known. Pro- 
teoglycans and glycosaminoglycans in other tissues have been 
implicated in such processes as tissue morphogenesis (2, 21, 
23),  cell  migration (2),  and maintenance of a  permeability 
barrier (20). In the context of nervous system development, 
there is evidence that a heparan sulfate proteoglycan produced 
by bovine corneal endothelial cells promotes neurite growth 
from cultured neurons (22). The availability of the Schwann 
cell-nerve  cell  culture  system  should  allow us to  begin  to 
probe the functions of these molecules in such cellular proc- 
esses as matrix assembly, neurite growth, Schwann cell prolif- 
eration and migration, and ensheathment and myelination of 
nerve fibers. 
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